FDA Blocks Nine More INDs; Cooperative Group Chairmen, DeVita Blast “Lack of Expertise”
In Brief: UICC Publishes International directory Of Cancer Centers; HSAs Still Worry NCI
It’s Official – UCLA Recognize As 19th Comprehensive Center
FDA Committee to Discuss Policy On Combinations
L.A. County Nears Crucial Decision On Construction Funds
Swiss Report On Radiotherapy Mortality Questioned
ACCC To Consider Cancer Act Changes HSA Problems
New Atlas Showing nonwhite Mortality Rates Available
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - In The Headlines: HHS shakeup threatens a legacy of medical breakthroughs
- Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy
- Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed
